LPL Financial’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $196K | Buy |
53,868
+2,100
| +4% | +$7.64K | ﹤0.01% | 4954 |
|
|
2025
Q1 | $99.4K | Buy |
51,768
+9,130
| +21% | +$17.5K | ﹤0.01% | 4915 |
|
|
2024
Q4 | $81K | Sell |
42,638
-1,497
| -3% | -$2.84K | ﹤0.01% | 4910 |
|
|
2024
Q3 | $58.3K | Sell |
44,135
-13,897
| -24% | -$18.3K | ﹤0.01% | 4873 |
|
|
2024
Q2 | $59.2K | Buy |
58,032
+40,187
| +225% | +$41K | ﹤0.01% | 4722 |
|
|
2024
Q1 | $32.7K | Buy |
+17,845
| New | +$32.7K | ﹤0.01% | 4727 |
|
|
2023
Q2 | – | Sell |
-28,596
| Closed | -$16K | – | 4536 |
|
|
2023
Q1 | $16K | Buy |
+28,596
| New | +$16K | ﹤0.01% | 4399 |
|
|
2020
Q3 | – | Sell |
-35,294
| Closed | -$479K | – | 3531 |
|
|
2020
Q2 | $479K | Sell |
35,294
-991
| -3% | -$13.5K | ﹤0.01% | 2410 |
|
|
2020
Q1 | $275K | Buy |
36,285
+1,526
| +4% | +$11.6K | ﹤0.01% | 2554 |
|
|
2019
Q4 | $220K | Buy |
34,759
+2,234
| +7% | +$14.1K | ﹤0.01% | 3008 |
|
|
2019
Q3 | $127K | Sell |
32,525
-1,023
| -3% | -$3.99K | ﹤0.01% | 3112 |
|
|
2019
Q2 | $162K | Sell |
33,548
-440
| -1% | -$2.13K | ﹤0.01% | 3062 |
|
|
2019
Q1 | $278K | Buy |
33,988
+5,725
| +20% | +$46.8K | ﹤0.01% | 2693 |
|
|
2018
Q4 | $156K | Buy |
28,263
+1,500
| +6% | +$8.28K | ﹤0.01% | 2867 |
|
|
2018
Q3 | $236K | Buy |
26,763
+7,314
| +38% | +$64.5K | ﹤0.01% | 2856 |
|
|
2018
Q2 | $194K | Buy |
+19,449
| New | +$194K | ﹤0.01% | 2969 |
|
|
2018
Q1 | – | Sell |
-23,559
| Closed | -$350K | – | 3161 |
|
|
2017
Q4 | $350K | Buy |
+23,559
| New | +$350K | ﹤0.01% | 2342 |
|
|
2017
Q2 | – | Sell |
-10,062
| Closed | -$90K | – | 2794 |
|
|
2017
Q1 | $90K | Sell |
10,062
-270
| -3% | -$2.42K | ﹤0.01% | 2624 |
|
|
2016
Q4 | $108K | Sell |
10,332
-164
| -2% | -$1.71K | ﹤0.01% | 2582 |
|
|
2016
Q3 | $94K | Buy |
+10,496
| New | +$94K | ﹤0.01% | 2539 |
|